Ahmed Borhan

• Managing development of field force teams across Gulf countries (UAE, Kuwait, Qatar, Bahrain, Oman & Yemen)
• Organized and coordinated training sessions for new employees.
• Analyzed data to assess effectiveness of current training offerings.
• Collaborated with department heads to design learning strategies aligned with organizational goals.
• Facilitated professional development workshops for groups and individuals.
• Developed and implemented coaching and mentorship programs for staff members.
• Monitored trainee progress through feedback from managers and supervisors.
• Created post-training evaluation surveys to measure performance improvements.

Managing Abu Dhabi & Al Ain private and institution business with Oman added recently to my responsibility. Working in Growth Hormone Deficiency therapeutic area promoting "Saizen", Merck's Somatropine along with Growzen, the digital Ecosystem that supports children having better outcomes, achieving more heights.

Key Achievements:

• Gained market leadership of 65% by June 2024.
• Closed S1 2024 with growth of 317% compared to S1 2023.
• Achieved 800% growth in 2023 compared to 2022, closing the year with 40% above the local sales target.
• Awarded as best achiever in Gulf for 2023

Managed private and institutional business in Al Ain region.
Promoted mature brands, Glucophage and Concor, in Diabetes and Cardiovascular therapeutic areas.
Developed strategies to enhance brand visibility and market share in competitive sectors.

Working in Multiple Sclerosis therapeutic area, promoting "Rebif" a platform therapy for MS and working on the pre-launch of "Mavenclad" Merck's breakthrough brand in managing MS.

Working on Cardiovascular therapeutic area, launching and promoting "SelokanZoc" a beta-blocker for different cardiovascular diseases.